Niagen Bioscience (NAGE)

• Market cap: $388M
• 1 day: 2.54%
• 5 days: -2.02%
• 1 month: 7.3%
• 3 months: -20.36%
• 6 months: -32.92%
• Year to date: -22.4%
• 1 year: -35.85%
• 5 years: -44.63%
• 10 years: 10.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 117